EUVIMEDEUVIMED entdecken
Crossref

The efficacy of intraoperative onabotulinumtoxinA in preventing hypertrophic scarring: a randomised, double-blind, split-scar trial with biomarker analysis

Lei Zhao, Zhike Zhou, Zixin Zhou, Qinghua Li

Advances in Dermatology and Allergology · 2026 · 43 (5) · 535-542

DOI: 10.5114/ada.2026.165985 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Dermatology and Allergology, 2026. Verfasst von Lei Zhao und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zhao, L., Zhou, Z., Zhou, Z., & Li, Q. (2026). The efficacy of intraoperative onabotulinumtoxinA in preventing hypertrophic scarring: a randomised, double-blind, split-scar trial with biomarker analysis. Advances in Dermatology and Allergology, 43(5), 535-542. https://doi.org/10.5114/ada.2026.165985

Vancouver

Zhao L, Zhou Z, Zhou Z, Li Q. The efficacy of intraoperative onabotulinumtoxinA in preventing hypertrophic scarring: a randomised, double-blind, split-scar trial with biomarker analysis. Advances in Dermatology and Allergology. 2026;43(5):535-542. doi:10.5114/ada.2026.165985

BibTeX
@article{Zhao2026,
  author = {Zhao, Lei and Zhou, Zhike and Zhou, Zixin and Li, Qinghua},
  title = {The efficacy of intraoperative onabotulinumtoxinA in preventing hypertrophic scarring: a randomised, double-blind, split-scar trial with biomarker analysis},
  journal = {Advances in Dermatology and Allergology},
  year = {2026},
  volume = {43},
  number = {5},
  pages = {535--542},
  doi = {10.5114/ada.2026.165985}
}
Kostenlos starten →